Skip to main content
FinSpry Logo
FinSpry
ALGS logo
ALGS
(NASDAQ)
Aligos Therapeutics, Inc.
$7.97-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aligos Therapeutics (ALGS) Stock Price & Financial Analysis

Aligos Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.33 - $8.00
52-Week High$13.69
52-Week Low$3.76
Open$7.47
Volume39.57K
Average Volume (3M)39.57K
Market Cap78.78M
Shares Outstanding9.88M
Price to Sales (P/S)35.00
Price to Book (P/B)1.43
EV/EBITDA-0.74
Revenue (TTM)2.19M
Net Income (TTM)-24.19M
Free Cash Flow (TTM)-82.94M
EPS (TTM)$-2.33
Profit Margin-1106.72%
Operating Margin-4024.93%
Return on Equity (ROE)-45.18%
Debt to Equity0.10
50-Day MA$7.28
200-Day MA$8.68
52-Week Change8.40%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Aligos Therapeutics

What is the current stock price for ALGS?

As of the latest trading session, ALGS stock trades at $7.97. The 52-week range is $3.76–$13.69, with a day range of $7.33–$8.00.

What is the P/E ratio for ALGS?

The P/E ratio (Price-to-Earnings) for ALGS is shown in the Key Statistics section. This valuation metric helps compare Aligos Therapeutics, Inc. to industry peers.

Does ALGS pay dividends?

Aligos Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALGS?

Based on 3 analysts, the consensus for ALGS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALGS?

Aligos Therapeutics's market capitalization is $78.8M, classifying it as a micro-cap company. Aligos Therapeutics operates in the Healthcare sector within the Biotechnology industry.